$70.0M
The Series A round included backing from British Patient Capital, F-Prime Capital, and Sofinnova Partners.
Tenpoint Therapeutics develops engineered cell-based therapies to restore vision.
Tenpoint Therapeutics is a biotechnology company developing cell-based therapeutics and in vivo reprogramming to reverse vision loss. The startup builds on scientific research in ocular therapies to replace lost and dysfunctional tissue in the eye.
Pete Coffey
Scientific Founder
Lyndon da Cruz
Scientific Founder
Deniz Dalkara
Scientific Founder
Olivier Goureau
Scientific Founder
Vanessa King
Scientific Founder
Thomas Reh
Scientific Founder
José-Alain Sahel
Scientific Founder
The Series A round included backing from British Patient Capital, F-Prime Capital, and Sofinnova Partners.